Clinical Trials Update: May 9, 2006
Colon Cancer Depression (Major/Severe) Ovarian Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
This study will evaluate the effects of folate supplementation and depletion on blood cells and colorectal cells. Volunteers 40-72 who have a history of colorectal adenomatous polyps and/or a family history of colorectal cancer or polyps may be eligible. Women must be two years post-menopausal, and patients must be ambulatory and in good health.
The research site is in New York City.
This study will evaluate how major depression is inherited. Candidates at least 21 years old who have had two or more episodes of depression, and have a brother, sister or parent who has had depression that began by age 40 may be eligible. Participants will be paid $75 for completing medical and psychiatric interviews and giving a small blood sample. You do not need to live near the study sites.
Research sites are located in the northeastern United States.
This study will compare treatment with a combination of an investigational drug and a marketed drug with the marketed drug alone in women with recurrent ovarian cancer. Study participants will be randomly assigned to one of the two treatment regimens. All study treatments and procedures will be provided at no cost to participants. Those who benefit from the study regimen will be permitted to continue receiving treatment.
Research sites are located throughout the United States and in Canada.
Copyright 2006 CenterWatch. All rights reserved.